CEO and Founder, Techstars
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
VP of Research and Special Initiatives, Google
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Severe neuropathologies are usually diagnosed after significant, largely irreversible brain damage already has occurred. Hear Philip Low, the founding chairman and CEO of NeuroVigil, whose goal is to reliably provide access to patients’ own brain health in real time. He has developed groundbreaking computational techniques that allow for a rapid quantification, analysis, and classification of data from a single channel of an electroencephalogram. Get more information and online registration here.